<DOC>
	<DOC>NCT00108537</DOC>
	<brief_summary>The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.</brief_summary>
	<brief_title>Non-Nicotine Agents for Smoking Cessation</brief_title>
	<detailed_description>This study is a two-arm open-label, randomized controlled trial of bupropion combined with transdermal nicotine versus high dose NRT (transdermal nicotine and nicotine inhaler) with all subjects receiving a behavioral counseling program for smoking cessation.</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Readiness to set a quit date in the next two weeks, Current smoking of at least 15 cigarettes a day Current untreated depression or receiving treatment for depression, History of seizures, major head injury, or other predisposition for seizures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>smoking</keyword>
	<keyword>nicotine</keyword>
	<keyword>drug therapy</keyword>
	<keyword>smoking cessation</keyword>
</DOC>